FUELCELL ENERGY INC (FCEL): what the price requires
At today's price, FUELCELL ENERGY INC (FCEL) is priced for today's economics sustained for ~39.1 years. boothcheck doesn't publish a fair value or a price target; it shows what the price assumes, so you can judge whether that bar is too high.
Generated: 2026-07-19 · Source: https://boothcheck.com/report/FCEL
Headline
| Field | Value |
|---|---|
| Ticker | FCEL |
| Company | FUELCELL ENERGY INC |
| Current price | $18.49/sh |
| Composition | Product 44% / Service 13% / Generation 30% / Advanced Technologies 13% |
What The Price Requires (Inversion)
The assumption today's price embeds, recovered by inverting the valuation.
| Field | Value |
|---|---|
| Inversion basis | revenue-multiple |
| EV / sales paid | 6.8x |
| Steady-state operating margin assumed | 3.1% |
| Must persist for | 39.1y |
The company earns no operating profit yet; the inversion runs on the revenue multiple and an assumed steady-state margin.
Solve inputs: computed at a 14.4% cost of capital; growth searched up to the 25% self-funding ceiling; each 1pp moves the implied horizon ~4.7 years.
Reconcile: at the x-ray's 9.3% required return this reads ~20.8 years; the models below use their own rates.
How unusual the bet is: elevated
| Reference | Value |
|---|---|
| vs own history | +0.65σ |
| sustained it ~10 years at this level | 15% |
| implied end-window share | 0% |
Valuation X-Ray
Every valuation family lands below the price. The price therefore requires assumptions beyond what those standard frames encode.
How the valuation models price the stock relative to the market price. Price/FV above 1.0 means the market pays more than that lens defends (expensive); at or below 1.0 the lens can defend the price.
| Family | Median price/FV | Models | Reads |
|---|---|---|---|
| Asset | 1.47x | 2 | expensive |
| Earnings | — | 0 | — |
| Relative | 2.39x | 2 | expensive |
| Growth | 2.82x | 2 | expensive |
Families that call it expensive: Relative, Growth
The models below discount at their own flat-beta convention rates (cost of equity 9.3%, WACC 9.2%); the inversion above states its own rate.
Per-Model Detail (n=6)
| Model | Family | FV | Price/FV | Applicable | Methodology |
|---|---|---|---|---|---|
| DCF Perpetual Growth | Growth | $0.00 | — | no | Negative/zero FCF — equity value floored at $0 |
| DCF Exit Multiple | Growth | $0.00 | — | no | Negative/zero FCF or EBITDA — equity value floored at $0 |
| Relative Valuation | Relative | $7.74 | 2.39x | yes | P/S fallback (negative EPS): Sector P/S 2.5x × TTM revenue — excluded from consensus |
| Simple DDM | Growth | — | — | no | — |
| Two-Stage DDM | Growth | — | — | no | — |
| Simple Excess Return | Asset | $13.27 | 1.39x | yes | Book value floor: BV/sh $13.27, ROE negative |
| Two-Stage Excess Return | Asset | $11.94 | 1.55x | yes | Book value with convergence: BV/sh $13.27, ROE converges to ke |
| Discounted Future Market Cap | Growth | $13.76 | 1.34x | yes | Rev $0.2B, growth 30% (input: historical growth; tapered), Terminal P/S: 4.8x / 6.0x / 7.2x (bear / base = today's held flat / bull, cap 12x) |
| Peter Lynch Fair Value | Relative | $0.00 | — | no | Negative/zero EPS — earnings-based value floored at $0 |
| Margin Trajectory | Growth | $4.31 | 4.29x | yes | Margin ramp: -50% → 12% over 7yr, rev growth 30% (input: historical growth; tapered) |
| Earnings Power Value | Earnings | — | — | no | — |
| Residual Income | Asset | — | — | no | — |
| Graham Number | Asset | — | — | no | — |
| EV/EBITDA Relative | Relative | — | — | no | — |
| FCF Yield | Earnings | — | — | no | — |
| SBC-Adj FCF Yield | Earnings | — | — | no | — |
| Ben Graham Formula | Earnings | — | — | no | — |
| ROIC-Justified P/B | Asset | — | — | no | — |
| P/Sales Sector | Relative | $7.74 | 2.39x | yes | Revenue $0.17B × sector P/S 2.5x |
| PEG Fair Value | Relative | — | — | no | — |
| Earnings Yield | Earnings | — | — | no | — |
| Funds From Operations Multiple | Relative | — | — | no | — |
| Clinical Phase NPV | Growth | — | — | no | — |
| Merton | Asset | — | — | no | — |
| V5 Mechanical | — | — | — | no | — |
Solvency
| Field | Value |
|---|---|
| Net cash | $299.9m |
| Interest coverage | -22.0x |
| Share count CAGR (dilution) | 21.6% |
| Burning cash | yes |
Operating profit is negative or near zero and the company has no demonstrated through-cycle (mid-cycle) operating margin to normalize against, so years-to-repay cannot be computed honestly.
Bullet Takeaways
FuelCell Energy is a pre-profit company priced on sales: at $24.02 (as of June 27, 2026) it trades at about 7.9x revenue, which implies an eventual operating margin near 3% with revenue growth beyond 25% a year sustained for roughly 40 years, an assumption the inversion calls extreme, and no valuation family reaches the price.
The loss is the central fact: Q2 2026 revenue was $35.6 million (down 5%) against a net loss of $77.6 million, trailing operating margin is near minus 110%, and the company is burning cash, so the roughly $380 million liquidity cushion is depleting rather than permanent.
Bull Case
Start with the balance sheet, because for a company still losing money it is the thing that buys time, and time is what the bull case needs. FuelCell Energy ended its January 2026 quarter with about $379.6 million of cash, restricted cash, and equivalents, against gross debt near $134 million, leaving the company in a net cash position of roughly $300 million. That liquidity is the runway: it lets management keep funding its core fuel-cell and electrolysis technology development while it works to push revenue past the cost of producing it. A pre-profit company that still holds more cash than debt is not in immediate distress, and that cushion is the first plank of any constructive view.
Management is acting like it believes in the path. The company executed a global restructuring across its U.S., Canada, and Germany operations explicitly to reduce operating costs and realign resources toward its core technologies, and the early effect is visible: operating expenses fell to $20.4 million from $27.6 million a year earlier, driven by lower research-and-development and administrative spending. Cutting cost while protecting the core technology stack is the right move for a company that needs to extend its runway and reach scale, and it signals management is managing the burn rather than ignoring it.
The opportunity, if it arrives, is large. FuelCell sells across product, service, generation, and advanced-technologies lines, positioning it for stationary power and hydrogen applications where demand could grow if clean baseload and electrolysis economics improve. The recent share-count reduction (a sharp drop reflecting a reverse split) means the share base is cleaner than the historical dilution suggests. The bull wager is simple to state: the cash buys several years, the cost cuts narrow the loss, and if any of the company's technologies reach commercial scale into a power-hungry, decarbonizing grid, the current revenue base is a small starting point rather than the ceiling.
Bear Case
The truth a FuelCell Energy holder would rather not face is that the company sells a real product at a steep loss and has done so for a long time. This is not a pre-revenue story, it is worse in one sense: revenue exists but the cost of generating it runs far above it. The second-quarter 2026 revenue was $35.6 million, down 5% year over year, against a net loss of $77.6 million, a loss roughly twice the size of sales. Trailing operating income is about minus $186 million on a trailing operating margin near minus 110%. After decades in business, FuelCell still loses more than a dollar of operating profit for every dollar of revenue, and that is the central fact the price has to argue past.
The valuation makes the argument almost impossible to win. No valuation family reaches the price: the stock is rich on assets, on earnings power, on peer multiples, and even on forward growth. At about 7.9x revenue the price implies the business eventually reaches a roughly 3% operating margin while sustaining revenue growth beyond 25% a year for around 40 years, an assumption the inversion flags as extreme, the most demanding end of the scale. When every frame says the price is a bet beyond what any standard method supports, the burden of proof is entirely on a future that has not arrived in many years of trying.
The cash cushion that the bull leans on is itself being consumed. The company is burning cash (interest coverage is deeply negative at about minus 18x), so the roughly $380 million of liquidity is a depleting asset, not a permanent one. The reverse split that cleaned up the share count is also a tell: companies that need to reverse-split have usually diluted heavily and seen the price fall far enough that a split is required to maintain listing standards, and nothing structurally prevents a return to issuing equity once the cash runs low. The bear case does not require the technology to be worthless; it only requires the gap between revenue and cost to stay wide for longer than the cash lasts, which is exactly what the track record suggests.
Valuation
FuelCell Energy is not yet earning a normal operating profit, so its price is set against sales rather than earnings. At about 7.9x revenue, the price implies the business eventually reaches an operating margin near 3% while sustaining revenue growth beyond 25% a year for roughly 40 years. That is a bound, not a solved point, and the inversion classifies the priced-in assumption as extreme, the most demanding end of the scale.
The method families are unanimous in the unusual direction: none of them reaches the price. The stock reads as rich on assets, on earnings power, on peer multiples, and even on forward growth. When every standard frame agrees the price exceeds what it can support, the valuation is not a disagreement to arbitrate, it is a single conclusion: the price embeds an outcome no conventional method can justify, and the buyer is underwriting a technology and adoption story rather than any current financial reality.
The honest read: this is a speculative bet on future commercialization, not a value or even a growth-at-a-reasonable-price case. The numbers that matter are the loss and the runway. Trailing operating income is about minus $186 million, the operating margin is near minus 110%, and the company is burning cash against roughly $380 million of liquidity, which is a depleting cushion. The valuation question is therefore not really about the multiple, it is about whether the cost-reduction program can narrow the loss and whether any of the company's technologies reach scale before the cash forces another capital raise. Treat the implied 40-year, beyond-25%-growth path as a flag that the price assumes near-perfection, not as a forecast.
Catalysts
The most recent earnings catalyst was the second-quarter 2026 report, which missed on both lines: revenue of $35.6 million (down 5% year over year, about 12% below estimates) and a net loss of $77.6 million, or $(1.45) per share, well below expectations. The cash position as of January 31, 2026 was about $379.6 million of cash, restricted cash, and equivalents (Simply Wall St, public.com, StockTitan).
The key strategic action has been cost reduction. FuelCell announced a global restructuring of its U.S., Canada, and Germany operations to cut operating costs and realign resources toward its core fuel-cell and electrolysis technologies, targeting a roughly 15% reduction in total operating costs. The early effect showed up in lower operating expenses, which fell to $20.4 million from $27.6 million, driven mainly by reduced research-and-development and administrative spending (Simply Wall St, FuelCell 8-K).
The forward catalysts are the burn rate and any commercial traction. The decisive questions are whether the cost cuts continue to narrow the loss, whether revenue stabilizes and grows, and how long the roughly $380 million of liquidity lasts before another capital raise becomes necessary. The stock has also been volatile on broader clean-power and AI-data-center power-demand sentiment, which can move it independent of fundamentals. The next quarterly print, and any order or partnership announcements for its stationary-power or hydrogen technologies, are the clearest near-term catalysts (StocksToTrade, StockTitan).
Peer Cohorts (Per Segment, With Filing Citations)
FuelCell Energy (consolidated) (reported)
- BE (Bloom Energy Corp)
- FY2025 10-K: …heat to achieve high efficiencies, we can provide highly efficient systems to customers based solely on their power needs and supplement with waste heat in more targeted applications. • Traditional backup equipment. As our Energy Server systems deliver reliable power, particularly in grid-independent configurations…
- FY2025 10-K: …cells can respond to grid fluctuations in milliseconds. Our fuel cell systems are equipped with embedded distributed intelligence that allows them to automatically adjust power output to maintain stable grid frequency and voltage, fulfilling critical ancillary services such as frequency regulation and spinning…
- GEV (GE Vernova Inc.)
- FY2025 10-K: …of onshore and offshore wind turbines and blades. • Our Electrification segment includes grid solutions, power conversion, electrification software, and solar and storage solutions technologies required for the transmission, distribution, conversion, storage, and orchestration of electricity from point of generation…
- FY2025 10-K: …31, 2025 , 2024 , and 2023 and the financial position as of December 31, 2025 and 2024 . We have reclassified certain prior year amounts to conform to the current year's presentation. The information presented in tables throughout the notes is presented in millions of U.S. dollars unless otherwise stated. Certain…
- BW (BABCOCK & WILCOX ENTERPRISES, INC.)
- FY2025 10-K: …nearly 160 years of experience providing diversified energy and emissions control solutions to a broad range of industrial, electrical utility, municipal and other customers. We support global energy needs and baseload power demand by providing advanced technologies that utilize coal, natural gas, hydrogen, waste and…
- FY2025 10-K: …included the divestiture of certain non-core assets, as described in Note 4 to the Consolidated Financial Statements. As a result of this assessment, we have determined we have one reportable segment, labeled as B&W. The revised segment presentation has been applied retrospectively to all periods presented. For…
Methodology Note
- Priced-in inversion: the valuation is inverted on the current price to recover the operating-income growth, duration, and steady-state margin the price embeds (ROE for financials, FFO growth for REITs).
- Valuation x-ray: the valuation models, grouped into four families (asset, earnings, relative, growth). Each model is expressed as a price/FV ratio (distance from price), not a point fair-value estimate. The spread across families is the disagreement.
- Solvency: net cash/debt, net-debt-to-NOPAT, interest coverage, and share-count CAGR from EDGAR financials (net debt / FFO and fixed-charge coverage for REITs; regulatory-capital framing for financials).
- Peer cohorts: per-segment comparables with deep-linkable SEC filing citations.
Fundamentals sourced from SEC EDGAR filings. Current price from Databento. The priced-in inversion and valuation x-ray are computed by the boothcheck engine; narrative composed by AI from the structured data.